TGF-beta in blood: a complex problem (Q33857618)

29 July 2017

1 reference

title

TGF-beta in blood: a complex problem (English)

1 reference

29 July 2017

Grainger DJ

1

1 reference

PubMed ID

10708961

29 July 2017

Mosedale DE

series ordinal

2

1 reference

PubMed ID

10708961

29 July 2017

Metcalfe JC

series ordinal

3

1 reference

29 July 2017

1 March 2000

1 reference

Cytokine and Growth Factor Reviews

29 July 2017

1 reference

29 July 2017

11

1 reference

29 July 2017

1-2

1 reference

29 July 2017

133-145

1 reference

Transforming growth factor-beta (TGF-beta)

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Requirement for activin A and transforming growth factor--beta 1 pro-regions in homodimer assembly.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Cellular and extracellular biology of the latent transforming growth factor-beta binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Latent transforming growth factor-beta: structural features and mechanisms of activation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Thrombospondin-1 is a major activator of TGF-beta1 in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

TGF-beta signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Transforming growth factor-beta in disease: the dark side of tissue repair

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Genetic events and the role of TGF beta in epithelial tumour progression

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

A pivotal role for TGF-beta in atherogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Cytokines and osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

The role of serum TGF-beta isoforms as potential markers of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

TGF-beta in the central nervous system: potential roles in ischemic injury and neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Elevated plasma levels of TGF-beta 1 in patients with invasive prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Elevated plasma levels of transforming growth factor (TGF)-beta1 and TGF-beta2 in patients with disseminated malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Elevated plasma levels of transforming growth factor-beta 1 in NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Plasma TGF beta in systemic sclerosis: a cross-sectional study.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Circulating transforming growth factor beta 1 and coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) secreted by cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Sandwich enzyme-linked immunosorbent assays (SELISAs) quantitate and distinguish two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) in complex biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Improved sandwich enzyme-linked immunosorbent assays for transforming growth factor beta 1

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Characterization of recombinant soluble human transforming growth factor-beta receptor type II (rhTGF-beta sRII).

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Molecular events in the processing of recombinant type 1 pre-pro-transforming growth factor beta to the mature polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Optimisation of CCL64-based bioassay for TGF-beta.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Quantification of transforming growth factor-beta in biological material using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Active and acid-activatable TGF-beta in human sera, platelets and plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Release and activation of platelet latent TGF-beta in blood clots during dissolution with plasmin

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Acquisition of secretion of transforming growth factor-beta 1 leads to autonomous suppression of scavenger receptor activity in a monocyte-macrophage cell line, THP-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Production of transforming growth factor beta by human peripheral blood monocytes and neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Expression and secretion of type beta transforming growth factor by activated human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

1 reference

7 January 2021

Changes in the concentration of insulin-like growth factor I and transforming growth factor beta1 in rat femoral bone during growth.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Pharmacokinetics and tissue distribution of recombinant human transforming growth factor beta 1 after topical and intravenous administration in male rats

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Hepatic processing of transforming growth factor beta in the rat. Uptake, metabolism, and biliary excretion

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Specific binding of endocrine transforming growth factor-beta 1 to vascular endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Urinary transforming growth factor-beta in patients with glomerular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

An alpha 2-macroglobulin receptor-dependent mechanism for the plasma clearance of transforming growth factor-beta 1 in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Two receptor systems are involved in the plasma clearance of tissue-type plasminogen activator (t-PA) in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Genetic control of the circulating concentration of transforming growth factor type beta1

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Transforming growth factor beta 1 is significantly elevated in plasma of patients suffering from renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Tamoxifen elevates transforming growth factor-beta and suppresses diet-induced formation of lipid lesions in mouse aorta

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Induction of Transforming Growth Factor β by the Antiestrogens Droloxifene, Tamoxifen, and Toremifene in MCF-7 Cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

An antibody present in normal human serum inhibits the binding of cytokines to their receptors in an in vitro system

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

The transforming growth factor-beta family

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Role of elevated plasma transforming growth factor-beta1 levels in wound healing

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Cells, matrix, growth factors, and the surgeon. The biology of scarless fetal wound repair

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Immunocytochemical localization and serologic detection of transforming growth factor beta 1. Association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Reduced serum level of transforming growth factor-beta in patients with IgA deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Plasma levels of transforming growth factor beta 1 in chronic liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Increased serum levels of transforming growth factor beta-1 in patients affected by thrombotic thrombocytopenic purpura (TTP): its implications on bone marrow haematopoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Elevated levels of plasma transforming growth factor-beta in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Determination of transforming growth factor beta 2 in human blood samples by ELISA

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

A relationship between TGF-beta 1 or IL-6 plasma levels and clinical features of spondyloarthropathies

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Elevation of bioactive transforming growth factor-beta in serum from patients with chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

Plasma concentrations of Lp(a) lipoprotein and TGF-beta1 are altered in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2899%2900037-4

7 January 2021

10.1016/S1359-6101(99)00037-4

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10708961